-
公开(公告)号:US20230143524A1
公开(公告)日:2023-05-11
申请号:US17796315
申请日:2022-01-21
申请人: LACTOMASON CO., LTD.
发明人: Minn SOHN , Tae Rahk KIM , Woo Jung PARK
IPC分类号: A61K35/747 , A61P29/00
CPC分类号: A61K35/747 , A61P29/00
摘要: The present disclosure relates to a strain of Lactobacillus reuteri LM1071 (KCCM12650P) and a composition for relieving menstrual pain, comprising the same.
A strain of Lactobacillus reuteri LM1071 (KCCM12650P) according to an embodiment of the present disclosure can relieve premenstrual syndrome by reducing NO, prostaglandin E2 and leukotriene in blood and increasing epoxyeicosatrienoic acid (EET) and the production ratio of prostaglandin E1/prostaglandin E2. Therefore, the strain can be applied to food compositions, health functional food compositions, pharmaceutical compositions and the like.-
公开(公告)号:US20240150707A1
公开(公告)日:2024-05-09
申请号:US18412654
申请日:2024-01-15
申请人: LACTOMASON CO., LTD.
发明人: Minn SOHN , Tae Rahk KIM
IPC分类号: C12N1/20 , A61K35/747 , A61P15/00 , C12R1/225
CPC分类号: C12N1/205 , A61K35/747 , A61P15/00 , C12R2001/225
摘要: The present disclosure relates to a strain of Lactobacillus gasseri LM1065 (KCCM13018P) and a composition of relieving premenstrual syndrome containing the strain.
A strain of Lactobacillus gasseri LM1065 (KCCM13018P) according to an embodiment of the present disclosure can relieve premenstrual syndrome by reducing NO in blood and TL-6 gene expression and increasing the production ratio of prostaglandin E1/prostaglandin E2 in blood and DGLA levels. Therefore, the strain can be applied to food compositions, health functional food compositions, pharmaceutical compositions, and the like.-
公开(公告)号:US20220002664A1
公开(公告)日:2022-01-06
申请号:US15734909
申请日:2020-09-25
申请人: LACTOMASON CO., LTD.
发明人: Min Gyu JEON , Tae Rahk KIM , Su Bin JO , Soo Yeon JEONG
IPC分类号: C12N1/20
摘要: The present disclosure relates to Lactobacillus reuteri LM1071 (KCCM12650P) and a composition containing Lactobacillus reuteri LM1071 for improving the intestinal environment.
Lactobacillus reuteri LM1071 (KCCM12650P) according to an embodiment of the present disclosure does not have hemolysis and biogenic amine production capability and has excellent biosafety and excellent intestine adhesion and thus can improve the intestinal environment and improve the intestinal health. Therefore, the strain can be applied to pharmaceutical compositions, food compositions, health functional food compositions, feed compositions, and the like.
-
-